Description

Sustanon 250 by PharmaQo is a pharmaceutical-grade injectable solution containing a blend of four testosterone esters delivering a total of 250 mg/mL. This formulation is used medically to treat male hypogonadism, testosterone deficiency, and select hormone replacement therapies (HRT), providing both immediate and sustained testosterone release.

The combination of short, medium, and long-acting esters allows for more stable testosterone levels with less frequent injections, under physician supervision.

Product Details:
Active Ingredients:

• Testosterone Propionate

• Testosterone Phenylpropionate

• Testosterone Isocaproate

• Testosterone Decanoate

Concentration: 250 mg/mL total blend

Form: Injectable solution (intramuscular)

Vial Size: 10 mL multidose vial

Pharmacokinetics:
Sustanon 250’s ester combination offers a half-life range from 1 to 15 days, allowing both rapid onset and long-lasting testosterone levels, making it suitable for weekly or biweekly administration depending on medical need.

Usage Recommendations:

• Indications: Male hypogonadism, testosterone deficiency, delayed puberty, gender-affirming hormone therapy (FTM), specific HRT protocols

• Typical Dosage (Medical Use): 250 mg every 2–3 weeks, adjusted as per lab monitoring and clinical evaluation

• Monitoring: Regular testosterone level checks, hematocrit, lipid profile, liver enzymes, PSA (prostate health)

• Cycle/Duration: Long-term therapy under medical supervision

Disclaimer:
This product is intended strictly for research and educational purposes. It is not for human use without a valid prescription and physician oversight. Not suitable for individuals under 18, pregnant or breastfeeding women, or those with health contraindications. Always comply with local medical laws and regulations.